Tumors

• Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

  David García-Vega, Sergio Cinza-Sanjurjo, Carlos Tilves-Bellas, Sonia Eiras, José R. González-Juanatey

  Rev Esp Cardiol. 2025;78:218-28